ZIM
GEN

Zacks Investment Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Zacks Investment Management’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-113,048
Closed -$392K – 711
2015
Q4 		$392K Buy
+113,048
New +$541K 0.01% 448
2015
Q2 		– Sell
-14,163
Closed -$101K – 755
2015
Q1 		$101K Buy
+14,163
New +$107K ﹤0.01% 612

Other funds holding GEN

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zacks Investment Management's GEN Position: Q1 2016 in Review

Zacks Investment Management sold out of Genesis Healthcare, Inc. (GEN) in Q1 2016, closing a stake of 113,048 shares — an estimated $392K sold.

Zacks Investment Management first reported a position in GEN in Q1 2015 and held it in 2 quarters. The position peaked at $392K in Q4 2015. 71 funds tracked by Wall St. Rank hold GEN as of Q1 2016.

  • Zacks Investment Management reported no remaining Genesis Healthcare, Inc. position as of Q1 2016 after selling out during the quarter.
  • Zacks Investment Management sold 113,048 Genesis Healthcare, Inc. shares in Q1 2016, an estimated $392K.
  • Zacks Investment Management first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 2 quarters.
  • Zacks Investment Management's Genesis Healthcare, Inc. position peaked at $392K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2016.

Based on Zacks Investment Management's 13F filing for Q1 2016, filed 12 May 2016.